Aimei Health Technology Co Ltd (AFJK) Stock Analysis

AI analysis of Aimei Health Technology Co Ltd (AFJK)

Hold

Aimei Health Technology Co Ltd (AFJK) is currently not a strong buy. The stock is trading at $12.20, significantly down 83.92% year-to-date, indicating severe volatility and potential instability. The RSI is at 50.187, suggesting it is neither overbought nor oversold, but the forward P/E ratio is 0, indicating a lack of earnings expectations. The company has recently faced negative news, including a failure to file its quarterly report on time and the termination of a merger agreement, which has likely shaken investor confidence. The main risk is the company's recent net income drop to -83,144 USD in Q2 2026, which raises concerns about its financial health. Overall, while there may be potential for recovery, the current situation warrants a cautious approach and a hold position for now.

Valuation Metrics

The current forward P/E ratio for Aimei Health Technology Co Ltd (AFJK) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued

5Y Average P/E

0.00

Current P/E

0.00

Overvalued

0.00

Undervalued

0.00

Forward EV/EBITDA

Strongly Undervalued

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued

0.00

Undervalued

0.00

Forward P/S

Fair

5Y Average P/S

0.11

Current P/S

0.00

Overvalued

1.24

Undervalued

-1.01

Alphio AI Price Scenarios for AFJK

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%AFJK

$14.53

Scenario price

B

Base

Base · 50%AFJK

$12.44

Scenario price

B

Bear

Bear · 25%AFJK

$10.38

Scenario price

Whales holding AFJK

W

W. R. Berkley Corporation

+ HoldingAFJK

+4.37%

3M Return

AFJK FAQ — answered by Alphio AI

Aimei Health Technology Co., Ltd. is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company do not have any specific business combination under consideration and has not nor has anyone on behalf, directly or indirectly, contacted any prospective target business. It has not generated any revenues. It operates in the Financials sector.

Aimei Health Technology Co Ltd (AFJK) is currently not a strong buy. The stock is trading at $12.20, significantly down 83.92% year-to-date, indicating severe volatility and potential instability. The RSI is at 50.187, suggesting it is neither overbought nor oversold, but the forward P/E ratio is 0, indicating a lack of earnings expectations. The company has recently faced negative news, including a failure to file its quarterly report on time and the termination of a merger agreement, which has likely shaken investor confidence. The main risk is the company's recent net income drop to -83,144 USD in Q2 2026, which raises concerns about its financial health. Overall, while there may be potential for recovery, the current situation warrants a cautious approach and a hold position for now.